Moreover, UBE2S overexpression promoted tumor cell proliferation, migration, and invasion through targeting degradation of p53 and the von Hippel-Lindau tumor suppressor [10, 11], and mutational inactivation of UBE2S attenuated malignant phenotypes [12]. This evidence concerns the gene TP53 and neoplasm.